Trexquant Investment LP Corbus Pharmaceuticals Holdings, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$1.5 - $9.38 $94,801 - $592,825	-63,201 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$4.79 - $8.39 $302,732 - $530,256	63,201 New	63,201 $530,000
Q4 2018 Feb 13, 2019	SELL	$5.26 - $7.97 $223,734 - $339,003	-42,535 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$4.65 - $7.95 $197,787 - $338,153	42,535 New	42,535 $321,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.27B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.